🕵️ 20/20 Biolabs, Inc. ($AIDX)
SEC insider & ownership activity, last 12 months · CIK 1139685 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Jul 16, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Jonathan M Cohen | 16.8% | 13D | Mar 3, 2026 | filing ↗ | |
| Streeterville Capital LLC | 9.9% | 13G | Feb 25, 2026 | filing ↗ | |
| Streeterville Management, LLC | 9.9% | 13G | Feb 25, 2026 | filing ↗ | |
| John M Fife | 9.9% | 13G | Feb 25, 2026 | filing ↗ | |
| Full Succeed International Limited | 6.3% | 13G | Mar 10, 2026 | filing ↗ | |
| Nengyuan Pan | 6.3% | 13G | Mar 10, 2026 | filing ↗ | |
| Wei Lu | 6.3% | 13G | Mar 10, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 16, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Earnings (2.02) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 19, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |